128 related articles for article (PubMed ID: 27853005)
1. Isotretinoin may affect pharmacokinetics of itraconazole in the skin: Is it rational to combine both for the treatment of dermatophytosis?
Srivastava A; Kothiwala SK
Indian J Dermatol Venereol Leprol; 2017; 83(1):68-69. PubMed ID: 27853005
[No Abstract] [Full Text] [Related]
2. Author's reply.
Ardeshna KP; Rohatgi S; Jerajani HR
Indian J Dermatol Venereol Leprol; 2017; 83(1):69-70. PubMed ID: 27917843
[No Abstract] [Full Text] [Related]
3. Successful treatment of recurrent dermatophytosis with isotretinoin and itraconazole.
Ardeshna KP; Rohatgi S; Jerajani HR
Indian J Dermatol Venereol Leprol; 2016; 82(5):579-82. PubMed ID: 27297276
[No Abstract] [Full Text] [Related]
4. Systemic treatment with isotretinoin suppresses itraconazole blood level in chronic granulomatous disease.
von Bernuth H; Wahn V
Pediatr Allergy Immunol; 2014 Jun; 25(4):405-7. PubMed ID: 24383787
[No Abstract] [Full Text] [Related]
5. Intracutaneous pharmacokinetics of oral antifungals and their relevance in recalcitrant cutaneous dermatophytosis: Time to revisit basics.
Sardana K; Arora P; Mahajan K
Indian J Dermatol Venereol Leprol; 2017; 83(6):730-732. PubMed ID: 28936991
[No Abstract] [Full Text] [Related]
6. ABSORICA (isotretinoin): a new form.
Scheinfeld N
Skinmed; 2013; 11(2):117-9. PubMed ID: 23745231
[No Abstract] [Full Text] [Related]
7. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis.
Sharma P; Bhalla M; Thami GP; Chander J
J Dermatolog Treat; 2020 Nov; 31(7):749-753. PubMed ID: 31030594
[No Abstract] [Full Text] [Related]
8. Itraconazole oral solution: pharmacokinetics and absorption.
Saag M
AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S16-7. PubMed ID: 11361746
[No Abstract] [Full Text] [Related]
9. Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
Khattab F; Elkholy BM; Taha M; Abd-Elbaset A; Fawzy M
Mycoses; 2022 Dec; 65(12):1194-1201. PubMed ID: 35943822
[TBL] [Abstract][Full Text] [Related]
10. Short treatment schedules of itraconazole in dermatophytosis.
Chow KW; Ting HC; Yap YP; Yee KC; Purushotaman A; Subramanian S; Badsha SA
Int J Dermatol; 1998 Jun; 37(6):446-8. PubMed ID: 9646134
[No Abstract] [Full Text] [Related]
11. Parameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytoses.
Sardana K; Khurana A; Gupta A
Expert Rev Clin Pharmacol; 2019 May; 12(5):443-452. PubMed ID: 30952196
[TBL] [Abstract][Full Text] [Related]
12. Improving bioavailability with a novel isotretinoin formulation (isotretinoin-Lidose).
Tan J; Knezevic S
Skin Therapy Lett; 2013; 18(6):1-3. PubMed ID: 24305729
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis.
Nagino K; Shimohira H; Ogawa M; Uchida K; Yamaguchi H
J Infect Chemother; 2000 Mar; 6(1):41-4. PubMed ID: 11810530
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the bioavailability of itraconazole.
Grant EM
Conn Med; 2000 Jul; 64(7):415-7. PubMed ID: 10946480
[No Abstract] [Full Text] [Related]
15. Comparison of two systemic antifungal agents, itraconazole and terbinafine, for the treatment of dermatophytosis in European hedgehogs (Erinaceus europaeus).
Bexton S; Nelson H
Vet Dermatol; 2016 Dec; 27(6):500-e133. PubMed ID: 27620985
[TBL] [Abstract][Full Text] [Related]
16. Reinterpreting minimum inhibitory concentration (MIC) data of itraconazole versus terbinafine for dermatophytosis - time to look beyond the MIC data?
Khurana A; Sardana K
Indian J Dermatol Venereol Leprol; 2018; 84(1):61-62. PubMed ID: 29243676
[No Abstract] [Full Text] [Related]
17. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics.
Willems L; van der Geest R; de Beule K
J Clin Pharm Ther; 2001 Jun; 26(3):159-69. PubMed ID: 11422598
[TBL] [Abstract][Full Text] [Related]
18. Treatment of tinea capitis - a critical appraisal.
Ginter-Hanselmayer G; Seebacher C
J Dtsch Dermatol Ges; 2011 Feb; 9(2):109-14. PubMed ID: 20969728
[TBL] [Abstract][Full Text] [Related]
19. Absence of in vivo-in vitro correlation in per-oral drug delivery.
Park K
J Control Release; 2014 Apr; 180():150. PubMed ID: 24679518
[No Abstract] [Full Text] [Related]
20. Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
Morimoto K; Tanuma H; Kikuchi I; Kusunoki T; Kawana S
Mycoses; 2004 Apr; 47(3-4):104-14. PubMed ID: 15078426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
